Latest California Healthline Stories
A JAMA study looking at county-specific federal data finds that the more opioid-related marketing dollars spent in a county, the higher rates of doctors who prescribed those drugs, and ultimately, more overdose deaths.
As drugmakers hike prices, interest to rein them in grows on Capitol Hill. Next week marks the anniversary of Roe v. Wade, the Supreme Court’s abortion decision, and both the House, whose leaders back abortion rights, and the Senate, controlled by abortion foes, are holding statement votes. And the government shutdown is still affecting health programs. Joanne Kenen of Politico, Margot Sanger-Katz of The New York Times and Alice Ollstein of Politico join KHN’s Julie Rovner to discuss these issues.
Loretta Boesing is on a mission to make sure prescription drugs delivered by mail are safe and effective. The life of her son — and others who order medicine by mail — could depend on it, she says.
The Food and Drug Administration is supposed to inspect all factories, foreign and domestic, that produce drugs for the U.S. market. But a KHN review of thousands of FDA documents — inspection records, recalls, warning letters and lawsuits — reveals how drugs that are poorly manufactured or contaminated can reach consumers.
From Medicare dental coverage to drug prices to fetal tissue research, the panelists answer listeners’ questions. Joanne Kenen of Politico, Stephanie Armour of The Wall Street Journal and Paige Winfield Cunningham of The Washington Post join KHN’s Julie Rovner.
It’s a little-known secret that patients can get thousands of dollars directly from a drugmaker.